GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $157,624,000 | +4.3% | 3,621,082 | +4.3% | 0.05% | +26.3% |
| Q1 2022 | $151,168,000 | -4.7% | 3,470,312 | -3.6% | 0.04% | -5.0% |
| Q4 2021 | $158,702,000 | +17.7% | 3,598,672 | +2.0% | 0.04% | +33.3% |
| Q3 2021 | $134,823,000 | -15.6% | 3,528,495 | -12.1% | 0.03% | -14.3% |
| Q2 2021 | $159,756,000 | -2.5% | 4,011,956 | -12.7% | 0.04% | -5.4% |
| Q1 2021 | $163,934,000 | -5.9% | 4,593,237 | -9.6% | 0.04% | -11.9% |
| Q4 2020 | $174,186,000 | -26.0% | 5,079,322 | -22.9% | 0.04% | -35.4% |
| Q3 2020 | $235,279,000 | -1.7% | 6,590,911 | +5.1% | 0.06% | -7.1% |
| Q2 2020 | $239,361,000 | +5.6% | 6,272,620 | +1.3% | 0.07% | -11.4% |
| Q1 2020 | $226,753,000 | -22.9% | 6,190,378 | -3.8% | 0.08% | 0.0% |
| Q4 2019 | $294,190,000 | +8.1% | 6,432,349 | -1.6% | 0.08% | +2.6% |
| Q3 2019 | $272,200,000 | +2.5% | 6,537,887 | -3.8% | 0.08% | +1.3% |
| Q2 2019 | $265,687,000 | -2.0% | 6,793,781 | +2.4% | 0.08% | -6.2% |
| Q1 2019 | $271,113,000 | +12.2% | 6,636,624 | -2.4% | 0.08% | +1.2% |
| Q4 2018 | $241,690,000 | -9.2% | 6,797,467 | -2.6% | 0.08% | +6.7% |
| Q3 2018 | $266,187,000 | -3.1% | 6,980,584 | -2.6% | 0.08% | -7.4% |
| Q2 2018 | $274,710,000 | +0.6% | 7,166,894 | +0.3% | 0.08% | 0.0% |
| Q1 2018 | $273,110,000 | +6.8% | 7,142,066 | -11.2% | 0.08% | +9.5% |
| Q4 2017 | $255,635,000 | -49.7% | 8,042,220 | -39.9% | 0.07% | -52.9% |
| Q3 2017 | $507,930,000 | -1.8% | 13,385,633 | +4.8% | 0.16% | -5.4% |
| Q2 2017 | $517,047,000 | +5.1% | 12,768,247 | +2.6% | 0.17% | +3.8% |
| Q1 2017 | $492,138,000 | +25.8% | 12,440,851 | +11.2% | 0.16% | +15.9% |
| Q4 2016 | $391,167,000 | -11.9% | 11,185,002 | -1.0% | 0.14% | -15.9% |
| Q3 2016 | $443,928,000 | -15.1% | 11,294,594 | -11.6% | 0.16% | -19.2% |
| Q2 2016 | $523,152,000 | +11.9% | 12,774,282 | +6.1% | 0.20% | +8.6% |
| Q1 2016 | $467,618,000 | +8.3% | 12,039,346 | +8.7% | 0.19% | +9.4% |
| Q4 2015 | $431,688,000 | +4.0% | 11,071,446 | -0.4% | 0.17% | -1.7% |
| Q3 2015 | $415,130,000 | -11.4% | 11,115,958 | -4.1% | 0.17% | -3.9% |
| Q2 2015 | $468,776,000 | -53.2% | 11,596,572 | -47.6% | 0.18% | -7.2% |
| Q1 2015 | $1,001,814,000 | +143.2% | 22,124,038 | +124.9% | 0.20% | +21.1% |
| Q4 2014 | $411,981,000 | -1.0% | 9,836,306 | +6.3% | 0.16% | -7.5% |
| Q3 2014 | $416,005,000 | -8.7% | 9,252,153 | +8.6% | 0.17% | -7.4% |
| Q2 2014 | $455,796,000 | +0.7% | 8,522,706 | +0.6% | 0.19% | -2.1% |
| Q1 2014 | $452,507,000 | +4.3% | 8,469,194 | +4.3% | 0.19% | +2.1% |
| Q4 2013 | $433,668,000 | +10.7% | 8,122,652 | +4.0% | 0.19% | +1.1% |
| Q3 2013 | $391,899,000 | +7.1% | 7,811,426 | +6.7% | 0.19% | -1.6% |
| Q2 2013 | $365,816,000 | – | 7,320,689 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |